371 related articles for article (PubMed ID: 15804918)
1. The apolipoprotein E epsilon4 allele and incident Alzheimer's disease in persons with mild cognitive impairment.
Aggarwal NT; Wilson RS; Beck TL; Bienias JL; Berry-Kravis E; Bennett DA
Neurocase; 2005 Feb; 11(1):3-7. PubMed ID: 15804918
[TBL] [Abstract][Full Text] [Related]
2. Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.
Devanand DP; Pelton GH; Zamora D; Liu X; Tabert MH; Goodkind M; Scarmeas N; Braun I; Stern Y; Mayeux R
Arch Neurol; 2005 Jun; 62(6):975-80. PubMed ID: 15956169
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein E epsilon4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging.
Hsiung GY; Sadovnick AD; Feldman H
CMAJ; 2004 Oct; 171(8):863-7. PubMed ID: 15477624
[TBL] [Abstract][Full Text] [Related]
4. [Dementia and cognitive impairment pattern: its association with epsilon4 allele of apolipoprotein E gene].
Rosich-Estragó M; Figuera-Terré L; Mulet-Pérez B; Arrufat-Cardús MT; Pascual San Emeterio A; Arbeola-Rigau I; Labad-Alquézar A; Vilella-Cuadrada E
Rev Neurol; 2004 May 1-15; 38(9):801-7. PubMed ID: 15152345
[TBL] [Abstract][Full Text] [Related]
5. Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease.
Lane R; Feldman HH; Meyer J; He Y; Ferris SH; Nordberg A; Darreh-Shori T; Soininen H; Pirttilä T; Farlow MR; Sfikas N; Ballard C; Greig NH
Pharmacogenet Genomics; 2008 Apr; 18(4):289-98. PubMed ID: 18334913
[TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.
Sunderland T; Mirza N; Putnam KT; Linker G; Bhupali D; Durham R; Soares H; Kimmel L; Friedman D; Bergeson J; Csako G; Levy JA; Bartko JJ; Cohen RM
Biol Psychiatry; 2004 Nov; 56(9):670-6. PubMed ID: 15522251
[TBL] [Abstract][Full Text] [Related]
7. Individual growth curve analysis of APOE epsilon 4-associated cognitive decline in Alzheimer disease.
Hoyt BD; Massman PJ; Schatschneider C; Cooke N; Doody RS
Arch Neurol; 2005 Mar; 62(3):454-9. PubMed ID: 15767511
[TBL] [Abstract][Full Text] [Related]
8. Relation of blood pressure to risk of incident Alzheimer's disease and change in global cognitive function in older persons.
Shah RC; Wilson RS; Bienias JL; Arvanitakis Z; Evans DA; Bennett DA
Neuroepidemiology; 2006; 26(1):30-6. PubMed ID: 16254451
[TBL] [Abstract][Full Text] [Related]
9. APOE genotype, family history of dementia, and Alzheimer disease risk: a 6-year follow-up study.
Huang W; Qiu C; von Strauss E; Winblad B; Fratiglioni L
Arch Neurol; 2004 Dec; 61(12):1930-4. PubMed ID: 15596614
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein E epsilon4 allele is unrelated to cognitive or functional decline in Alzheimer's disease: retrospective and prospective analysis.
Kleiman T; Zdanys K; Black B; Rightmer T; Grey M; Garman K; Macavoy M; Gelernter J; van Dyck C
Dement Geriatr Cogn Disord; 2006; 22(1):73-82. PubMed ID: 16699282
[TBL] [Abstract][Full Text] [Related]
11. Incidence and risk factors for mild cognitive impairment: a population-based three-year follow-up study of cognitively healthy elderly subjects.
Tervo S; Kivipelto M; Hänninen T; Vanhanen M; Hallikainen M; Mannermaa A; Soininen H
Dement Geriatr Cogn Disord; 2004; 17(3):196-203. PubMed ID: 14739544
[TBL] [Abstract][Full Text] [Related]
12. Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment.
Caselli RJ; Reiman EM; Locke DE; Hutton ML; Hentz JG; Hoffman-Snyder C; Woodruff BK; Alexander GE; Osborne D
Arch Neurol; 2007 Sep; 64(9):1306-11. PubMed ID: 17846270
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein E epsilon4, Alzheimer's disease, and cognitive performance in elderly Mexican Mestizos.
Villalpando-Berumen JM; Mejia-Arango S; Aguilar-Salinas CA; Ordonez-Sanchez ML; Gutierrez-Robledo LM
J Am Geriatr Soc; 2008 Apr; 56(4):677-82. PubMed ID: 18205760
[TBL] [Abstract][Full Text] [Related]
14. Effect of APOE ε4 allele on cortical thicknesses and volumes: the AddNeuroMed study.
Liu Y; Paajanen T; Westman E; Wahlund LO; Simmons A; Tunnard C; Sobow T; Proitsi P; Powell J; Mecocci P; Tsolaki M; Vellas B; Muehlboeck S; Evans A; Spenger C; Lovestone S; Soininen H;
J Alzheimers Dis; 2010; 21(3):947-66. PubMed ID: 20693633
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein E epsilon4 allele differentiates the clinical response to donepezil in Alzheimer's disease.
Bizzarro A; Marra C; Acciarri A; Valenza A; Tiziano FD; Brahe C; Masullo C
Dement Geriatr Cogn Disord; 2005; 20(4):254-61. PubMed ID: 16103669
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E epsilon4 allele differently affects the patterns of neuropsychological presentation in early- and late-onset Alzheimer's disease patients.
Marra C; Bizzarro A; Daniele A; De Luca L; Ferraccioli M; Valenza A; Brahe C; Tiziano FD; Gainotti G; Masullo C
Dement Geriatr Cogn Disord; 2004; 18(2):125-31. PubMed ID: 15211066
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E epsilon4 and age at onset of sporadic and familial Alzheimer disease in Caribbean Hispanics.
Olarte L; Schupf N; Lee JH; Tang MX; Santana V; Williamson J; Maramreddy P; Tycko B; Mayeux R
Arch Neurol; 2006 Nov; 63(11):1586-90. PubMed ID: 17101827
[TBL] [Abstract][Full Text] [Related]
18. Middle-aged children of persons with Alzheimer's disease: APOE genotypes and cognitive function in the Wisconsin Registry for Alzheimer's Prevention.
Sager MA; Hermann B; La Rue A
J Geriatr Psychiatry Neurol; 2005 Dec; 18(4):245-9. PubMed ID: 16306248
[TBL] [Abstract][Full Text] [Related]
19. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.
Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T
Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein E genotype and mortality: findings from the Cache County Study.
Hayden KM; Zandi PP; Lyketsos CG; Tschanz JT; Norton MC; Khachaturian AS; Pieper CF; Welsh-Bohmer KA; Breitner JC;
J Am Geriatr Soc; 2005 Jun; 53(6):935-42. PubMed ID: 15935014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
